Effect of Pelvic Floor Muscle Training on Urinary Incontinence Reports in Obese Women Undergoing a Low Calorie Diet

October 3, 2022 updated by: Pauliana Carolina de Souza Mendes, University of Sao Paulo

Effect of Pelvic Floor Muscle Training on Urinary Incontinence Reports in Obese Women Undergoing a Low Calorie Diet Prior to Bariatric Surgery: an Assessor Blinded Randomized Controlled Trial

The purpose of this study is to assess the efficacy of pelvic floor muscle training (PFMT) on urinary incontinence reports in obese women undergoing a low calorie diet prior to bariatric surgery for obesity. The study will also assess and compare rates of adherence to treatments, pelvic floor muscle function and women´s self perception of their PFM function, and satisfaction with treatment.

Study Overview

Detailed Description

According to the World Health Organization (WHO), the adult overweight rate in 2014 reached 20%, with the highest prevalence among women. In addition to metabolic diseases, obesity can cause musculoskeletal disorders, including pelvic floor muscle (PFM) disorders and urinary incontinence (UI) is the most prevalent one. Conservative intervention can be medication, lifestyle changes, but pelvic floor muscle training (PFMT) is considered the first-line conservative therapy for urinary incontinence in women and it is effective when delivered both individually or in group.

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Patients of the outpatient bariatric surgery service that will start a low calorie diet program as part of the bariatric presurgery routine of the service
  • Women
  • Over 18 years old
  • With body mass index greater than 30kg / m2
  • Who have reported urinary incontinence in the last four weeks
  • Who have the ability to contract the pelvic floor muscles
  • No report of neurological disease, no cognitive impairment
  • That are not pregnant.

Exclusion Criteria:

  • Women who do not wish to continue participating in the research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group 1- diet therapy (control)
Control group undergoing a low calorie diet will not receive supervised pelvic floor muscle training. This group will be assessed at baseline and after 12 weeks. For ethics reason at the end of the study women of the control group will be invited to receive the pelvic floor muscle training program. However, this will not be part of the study.
4 sets of 10 maximal perceived voluntary pelvic floor contractions sustained for 6 seconds, followed by 5 voluntary pelvic floor muscle contractions. The supervised 4 sets will be performed in 2 different positions (sitting and standing).
Experimental: Grupo 2 - low calorie diet + PFMT (experimental)
The experimental group will receive supervised pelvic floor muscle training in addition to a hypocaloric diet. Women will be instructed to perform daily pelvic floor muscle training at home. 4 sets of 10 maximal voluntary pelvic floor contractions sustained for 6 seconds, followed by 5 voluntary contractions of the pelvic floor muscles. The 4 sets will be performed in 2 different positions (sitting and standing). Once a month, they will receive a supervised in-person session using the same protocol described above, in the other weeks of the month will receive a session supervised by telephysiotherapy once a week. In addition to supervised sessions, women will be encouraged to perform the protocol three more days a week. In addition, they will be instructed to perform "the knack" maneuver.
4 sets of 10 maximal perceived voluntary pelvic floor contractions sustained for 6 seconds, followed by 5 voluntary pelvic floor muscle contractions. The supervised 4 sets will be performed in 2 different positions (sitting and standing).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self report of urinary incontinence by women
Time Frame: Women will be evaluated at baseline
Self report of urinary incontinence measured using question 3 of the ICIQ-SF. Women will be considered incontinent if they choose option 1,2,3,4,5 of question 3. Women will be considered continent if they choose option 0 of question 3.
Women will be evaluated at baseline
Severity and impact of Urinary incontinence in women´s quality of life
Time Frame: Women will be evaluated at baseline
the severity and impact of Urinary incontinence in women´s quality of life will be measured using the ICIQ-SF score
Women will be evaluated at baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participants' adherence to the PFMT protocol
Time Frame: Women will be evaluated at baseline and right after 12 weeks
Will be assessed using an exercise diary and the complier average causal effects (CACE) method
Women will be evaluated at baseline and right after 12 weeks
PFM function
Time Frame: Women will be evaluated at baseline
the modified Oxford grading scale- MOS (digital vaginal palpation)
Women will be evaluated at baseline
participants self-perception of their PFM function
Time Frame: Women will be evaluated at baseline
women´s self-perception of their PFM function according to the MOS categories
Women will be evaluated at baseline
Satisfaction with treatment
Time Frame: only after 12 weeks from the baseline assessment
Analogic visual scale where 0 represents no satisfaction with treatment and 10 the maximum satisfaction
only after 12 weeks from the baseline assessment
Subjective satisfaction with treatment
Time Frame: only after 12 weeks from the baseline assessment
Women will answer the following questions: are you satisfied with the treatment you received for UI? would you do this treatment again ? would you recomend this treatment ? to other people, would you chase another treatment ?
only after 12 weeks from the baseline assessment
Identification of barriers for the treatment
Time Frame: only after 12 weeks from the baseline assessment
Women will answer the following questions: Do identifie any barrier or difficulty to adhere to the treatment you received for urinary incontinence?
only after 12 weeks from the baseline assessment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 28, 2022

Primary Completion (Anticipated)

August 26, 2023

Study Completion (Anticipated)

December 26, 2023

Study Registration Dates

First Submitted

October 21, 2019

First Submitted That Met QC Criteria

November 7, 2019

First Posted (Actual)

November 12, 2019

Study Record Updates

Last Update Posted (Actual)

October 4, 2022

Last Update Submitted That Met QC Criteria

October 3, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Pelvic Floor Muscle Training

3
Subscribe